Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study

NCT05481736 is registered in ClinicalTrials.gov with COMPASS Pathways as lead sponsor.

NCT NCT05481736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05481736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study
Lead sponsor
COMPASS Pathways
Phase
Phase 2
Overall status
Completed
Start date
October 12, 2022
Completion date
November 18, 2024
Enrollment
32 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

anorexia nervosa